Exact Sciences Corporation
EXAS
$46.35
$0.461.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 713.42M | 708.66M | 699.26M | 637.52M | 646.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 713.42M | 708.66M | 699.26M | 637.52M | 646.89M |
| Cost of Revenue | 284.13M | 196.07M | 189.85M | 170.10M | 255.18M |
| Gross Profit | 429.29M | 512.59M | 509.42M | 467.42M | 391.70M |
| SG&A Expenses | 435.82M | 406.54M | 387.13M | 429.88M | 387.73M |
| Depreciation & Amortization | -71.06M | 24.44M | 23.31M | 23.31M | -68.85M |
| Other Operating Expenses | -- | -- | -- | -- | -2.03M |
| Total Operating Expenses | 748.51M | 727.15M | 721.17M | 733.90M | 688.00M |
| Operating Income | -35.08M | -18.50M | -21.91M | -96.38M | -41.12M |
| Income Before Tax | -875.97M | -37.43M | -14.35M | -108.42M | -50.38M |
| Income Tax Expenses | -11.38M | 808.00K | 1.46M | 1.81M | -610.00K |
| Earnings from Continuing Operations | -864.59M | -38.24M | -15.81M | -110.23M | -49.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -864.59M | -38.24M | -15.81M | -110.23M | -49.77M |
| EBIT | -35.08M | -18.50M | -21.91M | -96.38M | -41.12M |
| EBITDA | 18.06M | 36.28M | 31.09M | -42.43M | 13.05M |
| EPS Basic | -4.67 | -0.21 | -0.09 | -0.60 | -0.27 |
| Normalized Basic EPS | -0.12 | -0.06 | -0.07 | -0.34 | -0.08 |
| EPS Diluted | -4.67 | -0.21 | -0.09 | -0.60 | -0.27 |
| Normalized Diluted EPS | -0.12 | -0.06 | -0.07 | -0.34 | -0.08 |
| Average Basic Shares Outstanding | 185.31M | 184.80M | 184.31M | 182.35M | 181.11M |
| Average Diluted Shares Outstanding | 185.31M | 184.80M | 184.31M | 182.35M | 181.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
